doi:10.16139/j.1007-9610.2018.06.021

[1] Li T, Mello-Thoms C, Brennan PC.Descriptive epidemio-logy of breast cancer in China: incidence, mortality, survival and prevalence[J]. Breast Cancer Res Treat,2016,159(3):395-406.
[2] Pan BT, Johnstone RM.Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor[J]. Cell,1983,33(3):967-978.
[3] Davis JQ, Dansereau D, Johnstone RM, et al.Selective externalization of an ATP-binding protein structurally related to the clathrin-uncoating ATPase/heat shock protein in vesicles containing terminal transferrin receptors du-ring reticulocyte maturation[J]. J Biol Chem,1986,261(33):15368-15371.
[4] Johnstone RM, Adam M, Hammond JR, et al.Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)[J]. J Biol Chem,1987,262(19):9412-9420.
[5] Valadi H, Ekstrom K, Bossios A, et al.Exosome-media-ted transfer of mRNAs and microRNAs is a novel mecha-nism of genetic exchange between cells[J]. Nat Cell Biol,2007,9(6):654-659.
[6] Iero M, Valenti R, Huber V, et al.Tumour-released exosomes and their implications in cancer immunity[J]. Cell Death Differ,2008,15(1):80-88.
[7] Yu S, Cao H, Shen B, et al.Tumor-derived exosomes in cancer progression and treatment failure[J]. Oncotarget,2015,6(35):37151-37168.
[8] Thery C, Ostrowski M, Segura E.Membrane vesicles as conveyors of immune responses[J]. Nat Rev Immunol,2009,9(8):581-593.
[9] Zhang HG, Grizzle WE.Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions[J]. Am J Pathol,2014,184(1):28-41.
[10] Vader P, Breakefield XO, Wood MJ.Extracellular vesicles: emerging targets for cancer therapy[J]. Trends Mol Med,2014,20(7):385-393.
[11] Kooijmans SA, Vader P, van Dommelen SM, et al. Exosome mimetics: a novel class of drug delivery systems[J]. Int J Nanomedicine,2012,7:1525-1541.
[12] van Niel G, Porto-Carreiro I, Simoes S, et al. Exosomes: A common pathway for a specialized function[J]. J Biochem,2006,140(1):13-21.
[13] Cocucci E, Meldolesi J.Ectosomes and exosomes: shedding the confusion between extracellular vesicles[J]. Trends Cell Biol,2015,25(6):364-372.
[14] Antonyak MA, Li B, Boroughs LK, et al.Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells[J]. Proc Natl Acad Sci U S A,2011,108(12):4852-4857.
[15] Singh R, Pochampally R, Watabe K, et al.Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer[J]. Mol Cancer,2014,13:256.
[16] Gernapudi R, Yao Y, Zhang Y, et al.Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer[J]. Breast Cancer Res Treat,2015,150(3):685-695.
[17] Camacho L, Guerrero P, Marchetti D.MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes[J]. PLoS One,2013,8(9):e73790.
[18] Gwak JM, Kim HJ, Kim EJ, et al.MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer[J]. Breast Cancer Res Treat,2014,147(1):39-49.
[19] Baroni S, Romero-Cordoba S, Plantamura I, et al.Exosome-mediated delivery of miR-9 induces cancer-associa-ted fibroblast-like properties in human breast fibroblasts[J]. Cell Death Dis,2016,7(7):e2312.
[20] Tkach M, Thery C.Communication by extracellular vesicles: where we are and where we need to go[J]. Cell,2016,164(6):1226-1232.
[21] Ma L, Young J, Prabhala H, et al.miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis[J]. Nat Cell Biol,2010,12(3):247-256.
[22] O'Brien K, Rani S, Corcoran C, et al. Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells[J]. Eur J Cancer,2013,49(8):1845-1859.
[23] Luga V, Zhang L, Viloria-Petit AM, et al.Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration[J]. Cell,2012,151(7):1542-1556.
[24] Nabet BY, Qiu Y, Shabason JE, et al.Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer[J]. Cell,2017,170(2):352-366.
[25] Wen SW, Sceneay J, Lima LG, et al.The biodistribution and immune suppressive effects of breast cancer-derived exosomes[J]. Cancer Res,2016,76(23):6816-6827.
[26] Munich S, Sobo-Vujanovic A, Buchser WJ, et al.Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands[J]. Oncoimmunology,2012,1(7):1074-1083.
[27] Rong L, Li R, Li S, et al.Immunosuppression of breast cancer cells mediated by transforming growth factor-beta in exosomes from cancer cells[J]. Oncol Lett,2016,11(1):500-504.
[28] Hong EH, Chang SY, Lee BR, et al.Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells[J]. Int J Cancer,2013,132(12):2839-2848.
[29] Liu C, Yu S, Zinn K, et al.Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function[J]. J Immunol,2006,176(3):1375-1385.
[30] Clayton A, Tabi Z.Exosomes and the MICA-NKG2D system in cancer[J]. Blood Cells Mol Dis,2005,34(3):206-213.
[31] Clayton A, Mitchell JP, Court J, et al.Human tumor-derived exosomes down-modulate NKG2D expression[J]. J Immunol,2008,180(11):7249-7258.
[32] Gobbo J, Marcion G, Cordonnier M, et al.Restoring anticancer immune response by targeting tumor-derived exosomes with a HSP70 peptide aptamer[J]. J Natl Cancer Inst,2016,108(3).doi:10.1093
[33] Shedden K, Xie XT, Chandaroy P, et al.Expulsion of small molecules in vesicles shed by cancer cells: associa-tion with gene expression and chemosensitivity profiles[J]. Cancer Res,2003,63(15):4331-4337.
[34] Safaei R, Larson BJ, Cheng TC, et al.Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells[J]. Mol Cancer Ther,2005,4(10):1595-1604.
[35] Ciravolo V, Huber V, Ghedini GC, et al.Potential role of HER2-overexpressing exosomes in countering trastuzu-mab-based therapy[J]. J Cell Physiol,2012,227(2):658-667.
[36] Lv MM, Zhu XY, Chen WX, et al.Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein[J]. Tumour Biol,2014,35(11):10773-10779.
[37] Mao L, Li J, Chen WX, et al.Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs[J]. Tumour Biol,2016,37(4):5247-5256.
[38] Wei Y, Lai X, Yu S, et al.Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells[J]. Breast Cancer Res Treat,2014, 147(2):423-431.
[39] Boelens MC, Wu TJ, Nabet BY, et al.Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways[J]. Cell,2014,159(3):499-513.
[40] Pigati L, Yaddanapudi SC, Iyengar R, et al.Selective release of microRNA species from normal and malignant mammary epithelial cells[J]. PLoS One,2010,5(10): e13515.
[41] Eichelser C, Stuckrath I, Muller V, et al.Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients[J]. Oncotarget,2014,5(20):9650-9663.
[42] Hannafon BN, Trigoso YD, Calloway CL, et al.Plasma exosome microRNAs are indicative of breast cancer[J]. Breast Cancer Res,2016,18(1):90.
[43] Fang S, Tian H, Li X, et al.Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification[J]. PLoS One,2017,12(4):e175050.
[44] Kibria G, Ramos EK, Lee KE, et al.A rapid, automated surface protein profiling of single circulating exosomes in human blood[J]. Sci Rep,2016,6:36502.
[45] Lee SJ, Lee J, Kim WW, et al.Del-1 expression as a potential biomarker in triple-negative early breast cancer[J]. Oncology,2018,94(4):243-256.
[46] Joyce DP, Kerin MJ, Dwyer RM.Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer[J]. Int J Cancer,2016,139(7):1443-1448.
[47] Kim MS, Haney MJ, Zhao Y, et al.Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells[J]. Nanomedicine,2016,12(3):655-664.
[48] Pi F, Binzel DW, Lee TJ, et al.Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression[J]. Nature Nanotechnol,2018,13(1):82-89.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386.
[2]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391.
[3]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395.
[4]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402.
[5]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405.
[6]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420.
[9]	YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428.
[10]	PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467.
[11]	ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472.
[12]	WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477.
[13]	LIU Miao, SHEN Yan, FU Xiaohong, HU Jiaojiao, CHEN Qingqing, YING Tao. A comparative study on breast cancer between smaller and larger diameters using conventional ultrasound and contrast-enhanced ultrasound [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 229-233.
[14]	CHEN Yuanyuan, YE Xin, TANG Yongzhe, WANG Jie, HE Qi. Prognosis of invasive micropapillary carcinoma versus invasive ductal carcinoma of the breast: a comparative analysis after propensity score matching [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 353-360.
[15]	CHEN Xiaosong, LI Shuai, WU Jiayi, HUANG Ou, CHAI Weimin, YAO Jiejie, ZHU Ying, XU Chen, CHEN Jiayi, QU Qing, FEI Xiaochun, DING Xiaoyi, LIN Lin, ZHANG Nan, FANG Qiong, HE Jianrong, ZHU Li, LI Yafen, CHEN Weiguo, SHEN Kunwei. Diagnosis, treatment and survival of breast cancer patients in single large hospital: a 10-year analysis [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 149-158.